永笙-KY News Releases

[Evercord-KY] Announcement of Board Resolution to Lift Non-Compete Restrictions for Managers

Evercord-KY announced that its board of directors has resolved to lift the non-compete restrictions … · 2026-05-29

[StemCyte-KY] Announcement of Board Resolution to Waive Non-Compete Restrictions for Manager at Subsidiary Taiwan StemCyte

StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compe… · 2026-05-29

[EverCyte-KY] Announcement of Board Election of Chairman for Important Subsidiary Taiwan EverCyte

Taiwan EverCyte, an important subsidiary of EverCyte-KY, announced that Lu Kung-Ming has been electe… · 2026-05-29

【Ever Supreme Bio Tech】Announcement of Important Resolutions at the 2026 Annual General Meeting

Ever Supreme Bio Tech held its AGM on May 29, 2026, approving the 2025 loss compensation plan, finan… · 2026-05-29

[EverCyte-KY] Announcement of the change of corporate director representatives

EverCyte-KY announced that Diamond BioFund has reassigned its corporate director representatives to … · 2026-05-29

[Ever Supreme-KY] Announcement Regarding the Appointment of New Co-CEO

Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, C… · 2026-05-29

[EverCyte-KY] Announcement of the election of the Vice Chairman

EverCyte-KY announced the election of Lu Kong-ming as Vice Chairman by the Board of Directors on May… · 2026-05-29

[StemCyte-KY] Announcement of Director Change at Important Subsidiary StemCyte, Inc.

StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Hua… · 2026-05-29

[EverCyte-KY] Announcement of Change in Corporate Director Representatives and Board Composition for Important Subsidiary Taiwan EverCyte

Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors a… · 2026-05-29

[EverCyte-KY] Announcement of Change in General Manager of Important Subsidiary Taiwan EverCyte

Taiwan EverCyte, an important subsidiary of EverCyte-KY, announced a change in General Manager effec… · 2026-05-29

[StemCyte-KY] Announcement of Board Acting as AGM to Waive Non-Compete Restrictions for New Directors at Subsidiary Taiwan StemCyte

StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM … · 2026-05-29

[Evercord-KY] Announcement of Important Subsidiary Taiwan Cord Blood Bank's Board Exercising Shareholder Meeting Powers

Evercord-KY announced that its important subsidiary, Taiwan Cord Blood Bank, held a board meeting on… · 2026-05-29

[StemCyte-KY] Announcement of obtaining CPA's internal control system project review assurance report

StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review repor… · 2026-05-14

【Evershine-KY】Announcement of the Board of Directors' Approval of the Q1 2026 Consolidated Financial Report

Evershine-KY's Board of Directors approved the Q1 2026 consolidated financial report. The report ind… · 2026-05-13

【Yongshen-KY】Announcement on the Results of Price Stabilization Operations for the First Five Business Days After Listing

Yongshen-KY announced the results of its price stabilization operations during the first five busine… · 2026-05-07

[Yung Sheng-KY] Announcement of the Expected Board of Directors Meeting Date for the Company's Q1 2026 Consolidated Financial Report on May 13, 2026

Yung Sheng-KY announces that its board of directors meeting to review the Q1 2026 consolidated finan… · 2026-05-05

【Yong Sheng-KY】The Company's Stock Will Soon Terminate OTC Trading and Transfer to Taiwan Stock Exchange for Listing

Yong Sheng-KY will cease trading on the OTC market and list on the Taiwan Stock Exchange on April 30… · 2026-04-29

[Yon-Shen-KY] April 2026 Monthly Revenue: NT$0.33 Billion (YoY +29.7%)

Yon-Shen-KY announced its monthly revenue for April 2026 reached NT$0.33 billion, marking a signific… · 2026-04-01